Tue, November 7, 2023

Andrew Fein Maintained (ZNTL) at Strong Buy with Decreased Target to $46 on, Nov 7th, 2023

Andrew Fein of HC Wainwright & Co., Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Decreased Target from $55 to $46 on, Nov 7th, 2023.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $50 on, Thursday, August 10th, 2023
  • Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $38 on, Thursday, August 10th, 2023